A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Pacific Biosciences of California Inc’s current trading price is -62.09% away from its 52-week high, while its distance from the 52-week low is 8.54%. The stock’s price range for this time frame has been between $0.95 and $2.72. The trading volume of the company’s shares in the Healthcare reached around 1.76 million for the day, which was evidently lower than the average daily volume of 8.91 million over the last three months.
Pacific Biosciences of California Inc’s stock has seen a rocky market performance. The company’s stock achieved a 1-year high of $2.72 on 11/07/24, and the lowest price during that time was $0.95, recorded on 05/16/25.
How Financial Performance Impacts Market Capitalization
Pacific Biosciences of California Inc (PACB) has experienced a quarterly decline of -41.74% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 309.45M and boasts a workforce of 575 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.4233, with a change in price of -0.9050. Similarly, Pacific Biosciences of California Inc recorded 9,927,966 in trading volume during the last 100 days, posting a change of -46.89%.
How PACB’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for PACB stands at 7.63. Similarly, the long-term debt-to-equity ratio is also 7.60.
PACB Stock Stochastic Average
Pacific Biosciences of California Inc’s raw stochastic average for the past 50 days is currently at 13.87%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 24.97%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 25.53% and 21.62%, respectively.
PACB Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. Year to date metric has recorded a loss of -43.65%.However, over the last six months, we can see a stronger performance of -44.41%. Over the last 30 days, the price of PACB has leaped by -9.54%. And in the last five days, it has fallen by -10.33%.
